~~<i id='F534AED1D9'><strike id='F534AED1D9'><tt id='F534AED1D9'><pre id='F534AED1D9'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：explore 2025-10-01 12:12:16 Page View：9

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Stem cell clinics for heart failure: buyer be wary
Next article： Psychedelics group wrestles with new pharma identity

explore

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

3:10QueenJean,ofTrans-Liberation,speaksduringavigiltomemorializeO'ShaeSibleyatagasstation,Aug.4,2023

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

APPhoto/TedS.WarrenJoshBilenker’slastcompany,LoxoOncology,waspurchasedbyEliLillyfor$8billion.Nosurpr